InvestorsHub Logo
Followers 2
Posts 38
Boards Moderated 0
Alias Born 07/22/2014

Re: Rawnoc post# 95847

Friday, 08/01/2014 12:18:38 PM

Friday, August 01, 2014 12:18:38 PM

Post# of 146231
Of course there have been confirmed results by independent scientist. Just to name a few:

-Dr. Eva Harris, Division of Infectious Diseases and Vaccinology, Berkeley for Dengue
-Dr. Ken Rosenthal, Northeastern Ohio Universities Colleges of Medicine and Pharmacy, Herpes
-Dr. Krishna Menon, KARD Scientific, HIV and Flu
-Dr. Vivien Boniuk, Herpes. She did the studies before she became involved in the company as an investor. In fact she was so convinced by the results, that her family decided to invest heavily.
Of course you won't regard Dr. Menon and Dr. Boniuk as independent. That's OK.
There is no peer reviewed article that I am aware of. We disussed that in lenght. It is not necessary and makes no sense for the company to publish peer reviewed.
Obviously the FDA and european drug agencies found the results convincing enough to grant Orphan Drug Status for Denguecide.
Over the next months there will be probably a lot of results published by several universities and institutions, and I think this will finally resolve this discussion.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News